help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tam, S. P.
Right arrow Articles by Srivastava, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tam, S. P.
Right arrow Articles by Srivastava, G.

Endocrinology, Vol 137, 418-424, Copyright © 1996 by Endocrine Society


ARTICLES

Gene expression of hypothalamic somatostatin, growth hormone releasing factor, and their pituitary receptors in hypothyroidism

SP Tam, KS Lam and G Srivastava
Department of Medicine, University of Hong Kong, Hong Kong.

Thyroid hormones are important to growth in mammals and have been shown to rapidly stimulate the rate of GH gene transcription. In this study, we investigated whether thyroid hormones modulate GH secretion through their effects on the gene expression of GRF, somatostatin (SS), GRF receptor, and receptor subtype 2 for SS (SSTR2). Male adult Sprague- Dawley rats were rendered hypothyroid with a single injection of propylthiouracil followed by methimazole in drinking water (0.02%) for 1 day to 12 weeks. Total RNA extracted from the anterior pituitary and hypothalamus was analyzed by Northern hybridization. GH messenger RNA (mRNA) level in the anterior pituitary was significantly reduced in the hypothyroid animals (P < 0.0001 vs. controls for all treatment duration > or = 1 week). An increase in hypothalamic GRF mRNA level, by 2- and 4- fold, respectively, was seen after 3 and 12 weeks of antithyroid treatment (both P < 0.001 vs. controls). Hypothalamic GRF content, studied in 12-week hypothyroid rats only, was decreased compared with controls (P < 0.05). A reduction in pituitary GRF receptor mRNA level was observed after 1 week of antithyroid treatment (P < 0.01 after 1 week, P < 0.001 after 3 weeks). Total hypothalamic SS content and SS mRNA level in hypothalamic fragments consisting predominantly of the paraventricular and periventricular nuclei became significantly decreased (P < 0.05 and P < 0.005 respectively) after 12-weeks of antithyroid treatment. The reduction in SS gene expression in the periventricular nuclei was confirmed by in situ hybridization. No significant change in the mRNA level of pituitary SSTR2 was observed up to 12 weeks of antithyroid treatment. In conclusion, we have demonstrated a reduction in the gene expression of GRF receptor and SS in the hypothyroid rat. Our results suggest that the changes in hypothalamic GRF and SS gene expression in hypothyroid rats may be compensatory in nature and are likely to be secondary to the reduction in GH synthesis and secretion in these animals. The reduction in basal and GRF-stimulated GH secretion in hypothyroidism can be explained by the observed reduction in GH and GRF receptor gene expression.


This article has been cited by other articles:


Home page
J Trop PediatrHome page
A. T. Soliman, M. Omar, A. E. Awwa, M. M. Rizk, R. K. El Alaily, and E. M. A. Bedair
Linear Growth, Growth-Hormone Secretion and IGF-I Generation in Children with Neglected Hypothyroidism Before and After Thyroxine Replacement
J Trop Pediatr, May 1, 2008; (2008) fmn030v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Bedard, J. Strecko, K. Theriault, J. Bedard, C. Veyrat-Durebex, and P. Gaudreau
Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E740 - E751.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Nogami, M. Matsubara, T. Harigaya, M. Katayama, and K. Kawamura
Retinoic Acids and Thyroid Hormone Act Synergistically with Dexamethasone to Increase Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Expression
Endocrinology, December 1, 2000; 141(12): 4396 - 4401.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Nogami, K. Inoue, H. Moriya, A. Ishida, S. Kobayashi, S. Hisano, M. Katayama, and K. Kawamura
Regulation of Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Expression by Glucocorticoids in MtT-S Cells and in the Pituitary Gland of Fetal Rats
Endocrinology, June 1, 1999; 140(6): 2763 - 2770.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. L. Miller and K. E. Mayo
Glucocorticoids Regulate Pituitary Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Expression
Endocrinology, June 1, 1997; 138(6): 2458 - 2465.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Aleppo, S. F. Moskal II, P. A. De Grandis, R. D. Kineman, and L. A. Frohman
Homologous Down-Regulation of Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Levels
Endocrinology, March 1, 1997; 138(3): 1058 - 1065.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society